Methyl 6-Bromohexanoate | CAS:14273-90-6

We serve Methyl 6-Bromohexanoate CAS:14273-90-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Methyl 6-Bromohexanoate

Chemical Name:   Methyl 6-Bromohexanoate
CAS.NO:14273-90-6
Synonyms:
6-BROMO-HEXANOIC ACID METHYL ESTER
Methyl 6-bromohexanoate

Molecular Formula:C7H13BrO2
Molecular Weight: 209.08100

Physical and Chemical Properties:
Density: 1.3g / cm3
Boiling point: 209.2ºC at 760mmHg
Flash point: 106.8ºC
Refractive index: 1.459

Specification:
Appearance:Clear colorless to pale yellow liquid
Purity:≥99.0%
Moisture Content: ≤0.25%
Impurity: ≤0.3%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep away from heat, sparks, and flame. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area.
Application:An important raw material and intermediate used in Organic Synthesis,Pharmaceuticals.



Contact us for information like Methyl 6-Bromohexanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 6-bromohexanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 6-Bromohexanoate Use and application,6-BROMO-HEXANOIC ACID METHYL ESTER technical grade,usp/ep/jp grade.


Related News: Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.2-Amino-3-nitropyridine manufacturer Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.3',5'-Bis-O-(4-chlorobenzoyl)-2-deoxy-5-azacytosine supplier Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.2-(2-bromoethoxy)-1,3,5-trichlorobenzene vendor Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.